Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.


TSXV:THRM - Post by User

Comment by Smokey1958on Sep 27, 2021 8:40am
201 Views
Post# 33922999

RE:RE:Therma is a $.05 cent stock without test

RE:RE:Therma is a $.05 cent stock without test

If you're looking at THRM through the lense of a 3 year chart ...you are playing with numbers. It is not even close to being the company it was 3 years ago. To ignore the general trends on the junior markets over this time also fails to see another influencing factor. Consider, instead, using an 18 month chart, placing this chart over the the chart of the mayhem that has been the junior exchanges .....particularly over the last 6 months.

Note the sudden surge in many stocks in February of 2021 and the significant decline since. There is nothing to suggest the stock would fall anywhere near what you are speculating. In fact all analyses point to far more stability ...even as low daily trading volumes make for THRM being easily and consistently manipulated by day traders.
 


InvrsContrarian wrote: With the other approval timelines being actively researched, I'd hate to say it but a descending channel on the three year chart appears to be forming with a 3 month timeline reaching the 0.15 to 0.25 target. I don't know what the consensus is about time to approval once submitted, but without any more pertinent news until approval, this chart doesn't look to good. Lower lows, lower highs.

Lockdown2020 wrote: Stop with the valuation nonsense until FDA approval.If it happens great ,if not then back to 5 cents .Stop misleading shareholders !!!
imho




<< Previous
Bullboard Posts
Next >>